ARCHIVES

FDA IND Approval Of New Cancer Drug Is First Based On Phase 1 Clinical Trials In Europe

This article is from The Cancer Letter archive.

Vol. 12 No. 47 | December 5, 1986

Download PDF Visit The Full Archive

Related Articles

Healy Attacks Scripps-Sandoz Research Deal, Rep. Wyden Asks For HHS Investigation

March 19, 1993

NCI Programs: Researchers Take “Director’s Challenge” to Develop Molecular Profiles of Tumors

December 10, 1999

Drugs and Targets: FDA approves Velcade in mantle cell lymphoma

October 17, 2014

Phase III PANORAMA-1 Trial Meets PFS Primary Endpoint

June 27, 2014

President’s Cancer Panel urges comprehensive health care reform, provision of services for cancer survivors.

June 4, 2004

Evidence Lacking On Value of Vitamins to Prevent Disease, Panel Says.

June 16, 2006